← Back to Patent Explorer
US4430432A Expired / Lapsed US ⏱️ 0.0 years remaining

Endo-deoxyribonuclease and process for the production thereof

Assignee: RIKEN
•
Filing: 1982-03-01
•
Granted: 1984-02-07
•
Expires: 2002-03-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel Endo-deoxyribonuclease A (Endo-DNase A) which has the substrate specificity of recognizing specific base sequence in double-stranded deoxyribonucleic acid (DNA) molecules and cleaving the strands at specified sites in the DNA to produce specific DNA fragments and, a process for the production of the Endo-DNase A by culturing a microorganism belonging to the genus Saccharomyces or Pichia.

Inventors

  • 👤 Tadahiko Ando
  • 👤 Takehiko Shibata
  • 👤 Hiroomi Watabe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 07:31
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/16; C12N9/22; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/911; Y10S435/938; Y10S435/94

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 200 words
Endo-deoxyribonuclease A (Endo-DNase A) which has the substrate specificity of recognizing specific base sequence in double-stranded deoxyribonucleic acid (DNA) molecules and cleaving the strands at specified site(s) in the DNA to produce specific DNA fragments: the DNase A being capable of recognizing the following nucleotide sequence in the molecule of pBR 322 DNA and cleaving the said DNA in one position sequence at the indicated vertical arrows, ##STR2## and cleaving φ105C phage DNA and M2 phage DNA in several positions, and λ phage DNA, φNR2 phage DNA, φ1 phage DNA, SPP1 phage DNA and ρ11 phage DNA in many positions; having the optimum pH of 6.5 to 10.0 in 50 mM Tris-HCL buffer; having the working temperature of about 30° to about 37° C.; being activated with Mg ++ or Mn ++ ; being inhibited with more than 0.2 M of NaCl or KCl, and having molecular weight of about 80,000 daltons measured by a gel filtration method using Ultro gel AcA 44, said enzyme being obtained from a cell-free extract of a DNaseA-producing microorganism belonging to the genus Saccharomyces or Pichia in a culture medium, collecting the cells thereof, obtaining cell-free extract therefrom, separating and collecting the DNase A.
Claim 2
Dependent Claim 200 words
Endo-deoxyribonuclease A (Endo-DNase A) which has the substrate specificity of recognizing specific base sequence in double-stranded deoxyribonucleic acid (DNA) molecules and cleaving the strands at specified site(s) in the DNA to produce specific DNA fragments: the DNase A being capable of recognizing the following nucleotide sequence in the molecule of pBR 322 DNA and cleaving the said DNA in one position sequence at the indicated vertical arrows, ##STR2## and cleaving φ105C phage DNA and M2 phage DNA in several positions, and λ phage DNA, φNR2 phage DNA, φ1 phage DNA, SPP1 phage DNA and ρ11 phage DNA in many positions; having the optimum pH of 6.5 to 10.0 in 50 mM Tris-HCL buffer; having the working temperature of about 30° to about 37° C.; being activated with Mg ++ or Mn ++ ; being inhibited with more than 0.2 M of NaCl or KCl, and having molecular weight of about 80,000 daltons measured by a gel filtration method using Ultro gel AcA 44, said enzyme being obtained from a cell-free extract of a DNaseA-producing microorganism belonging to the genus Saccharomyces or Pichia in a culture medium, collecting the cells thereof, obtaining cell-free extract therefrom, separating and collecting the DNase A.
Claim 3
Dependent Claim 43 words
A process for the production of the Endo-DNase A as defined claim 1 which comprises culturing a DNase A-producing microorganism belonging to the genus Saccharomyces, collecting the cells, obtaining cell-free extract therefrom, and separating and collecting the DNase A from the cell-free extract.
Claim 4
Dependent Claim 43 words
The process of claim 2 in which the cell-free extract is treated to remove nucleic acid fraction therefrom, and at least one method selected from ammonium sulfate fractionation, ion exchange chromatography and gel filtration is used to separate and collect the DNase A.
Claim 5
Dependent Claim 43 words
A process for the production of the Endo-DNase A as defined claim 1 which comprises culturing a DNase A-producing microorganism belonging to the genus Pichia, collecting the cells, obtaining cell-free extract therefrom, and separating and collecting the DNase A from the cell-free extract.
Claim 6
Dependent Claim 43 words
The process of claim 4 in which the cell-free extract is treated to remove nucleic acid fraction therefrom, and at least one method selected from ammonium sulfate fractionation, ion exchange chromatography and gel filtration is used to separate and collect the DNase A.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-02-06 1987-08-08 1988-02-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-02-06 1991-08-08 1992-02-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-02-06 1995-08-08 1996-02-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag